INDIVIOR PLC (INDV) Stock Fundamental Analysis
NASDAQ:INDV - Nasdaq - GB00BN4HT335 - Common Stock - Currency: USD
We assign a fundamental rating of 4 out of 10 to INDV. INDV was compared to 198 industry peers in the Pharmaceuticals industry. INDV has only an average score on both its financial health and profitability. INDV has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year INDV has reported negative net income.
INDV had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: INDV reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: INDV reported negative operating cash flow in multiple years.
1.2 Ratios
With a decent Return On Assets value of -3.93%, INDV is doing good in the industry, outperforming 76.26% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 111.88%, INDV belongs to the top of the industry, outperforming 99.49% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for INDV is in line with the industry average of 41.62%.
The last Return On Invested Capital (111.88%) for INDV is above the 3 year average (43.06%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.93% | ||
| ROE | N/A | ||
| ROIC | 111.88% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
1.3 Margins
In the last couple of years the Profit Margin of INDV has declined.
Looking at the Operating Margin, with a value of 25.44%, INDV belongs to the top of the industry, outperforming 89.90% of the companies in the same industry.
INDV's Operating Margin has been stable in the last couple of years.
INDV has a better Gross Margin (83.98%) than 88.38% of its industry peers.
In the last couple of years the Gross Margin of INDV has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.44% | ||
| PM (TTM) | N/A | ||
| GM | 83.98% |
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), INDV is creating value.
The number of shares outstanding for INDV has been reduced compared to 1 year ago.
Compared to 5 years ago, INDV has less shares outstanding
The debt/assets ratio for INDV is higher compared to a year ago.
2.2 Solvency
INDV has an Altman-Z score of 2.78. This is not the best score and indicates that INDV is in the grey zone with still only limited risk for bankruptcy at the moment.
INDV has a better Altman-Z score (2.78) than 73.74% of its industry peers.
The Debt to FCF ratio of INDV is 2.49, which is a good value as it means it would take INDV, 2.49 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.49, INDV belongs to the top of the industry, outperforming 91.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.49 | ||
| Altman-Z | 2.78 |
ROIC/WACC10.83
WACC10.33%
2.3 Liquidity
A Current Ratio of 0.88 indicates that INDV may have some problems paying its short term obligations.
With a Current ratio value of 0.88, INDV is not doing good in the industry: 84.85% of the companies in the same industry are doing better.
INDV has a Quick Ratio of 0.88. This is a bad value and indicates that INDV is not financially healthy enough and could expect problems in meeting its short term obligations.
INDV has a worse Quick ratio (0.72) than 84.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
INDV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1698.07%.
INDV shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -55.78% yearly.
The Revenue has grown by 83.27% in the past year. This is a very strong growth!
Measured over the past years, INDV shows a quite strong growth in Revenue. The Revenue has been growing by 8.64% on average per year.
EPS 1Y (TTM)-1698.07%
EPS 3Y-77.57%
EPS 5Y-55.78%
EPS Q2Q%10.81%
Revenue 1Y (TTM)83.27%
Revenue growth 3Y14.52%
Revenue growth 5Y8.64%
Sales Q2Q%-6.34%
3.2 Future
Based on estimates for the next years, INDV will show a small growth in Earnings Per Share. The EPS will grow by 5.66% on average per year.
Based on estimates for the next years, INDV will show a small growth in Revenue. The Revenue will grow by 2.59% on average per year.
EPS Next Y-20.5%
EPS Next 2Y-3.84%
EPS Next 3Y2.76%
EPS Next 5Y5.66%
Revenue Next Year-9.27%
Revenue Next 2Y-2.74%
Revenue Next 3Y0.06%
Revenue Next 5Y2.59%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for INDV. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 7.80 indicates a rather cheap valuation of INDV.
Based on the Price/Forward Earnings ratio, INDV is valued cheaper than 93.43% of the companies in the same industry.
INDV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 20.74.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 7.8 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INDV indicates a rather cheap valuation: INDV is cheaper than 97.47% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, INDV is valued cheaply inside the industry as 89.90% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.25 | ||
| EV/EBITDA | 2.64 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.84%
EPS Next 3Y2.76%
5. Dividend
5.1 Amount
No dividends for INDV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
11.9
-0.08 (-0.67%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners89.83%
Inst Owner Change-0.15%
Ins Owners3.68%
Ins Owner ChangeN/A
Market Cap1.48B
Analysts82.5
Price Target15.4 (29.41%)
Short Float %2.03%
Short Ratio1.69
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.35%
PT rev (3m)-6.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-15.8%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 7.8 | ||
| P/S | 0.72 | ||
| P/FCF | 11.25 | ||
| P/OCF | 8.94 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 2.64 |
EPS(TTM)-0.37
EYN/A
EPS(NY)1.52
Fwd EY12.81%
FCF(TTM)1.06
FCFY8.89%
OCF(TTM)1.33
OCFY11.18%
SpS16.51
BVpS-2.28
TBVpS-2.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.93% | ||
| ROE | N/A | ||
| ROCE | 141.62% | ||
| ROIC | 111.88% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 25.44% | ||
| PM (TTM) | N/A | ||
| GM | 83.98% | ||
| FCFM | 6.41% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)54.5%
ROCE(5y)38.6%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
F-Score5
Asset Turnover1.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.49 | ||
| Debt/EBITDA | 0.57 | ||
| Cap/Depr | 136% | ||
| Cap/Sales | 1.65% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.24% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 2.78 |
F-Score5
WACC10.33%
ROIC/WACC10.83
Cap/Depr(3y)163.83%
Cap/Depr(5y)132.28%
Cap/Sales(3y)2.67%
Cap/Sales(5y)2.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1698.07%
EPS 3Y-77.57%
EPS 5Y-55.78%
EPS Q2Q%10.81%
EPS Next Y-20.5%
EPS Next 2Y-3.84%
EPS Next 3Y2.76%
EPS Next 5Y5.66%
Revenue 1Y (TTM)83.27%
Revenue growth 3Y14.52%
Revenue growth 5Y8.64%
Sales Q2Q%-6.34%
Revenue Next Year-9.27%
Revenue Next 2Y-2.74%
Revenue Next 3Y0.06%
Revenue Next 5Y2.59%
EBIT growth 1Y103.89%
EBIT growth 3Y11.69%
EBIT growth 5Y7.28%
EBIT Next Year11.33%
EBIT Next 3Y10.91%
EBIT Next 5Y12.03%
FCF growth 1Y473.91%
FCF growth 3Y-74.97%
FCF growth 5Y-48.94%
OCF growth 1Y374.29%
OCF growth 3Y-53.28%
OCF growth 5Y-24.93%